Back to all studies
🧴
Phase 4
Dermatology
in-person
Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
Sponsored by Northwestern University
Compensation
$500–$2,500
Duration
3 months
Location
Illinois
About this study
Single center, prospective, Open label study of sleep, pruritus and circadian function pre/post 12-weeks of dupilumab treatment in children 6-17 years old
Who can participate
- • Adults aged 6–17
- • All genders welcome
- • Diagnosed with or experiencing atopic dermatitis
- • Able to attend in-person clinic visits
What's included
- • Compensation up to $2,500
- • All study-related medical care at no cost
- • Lab work, screenings, and physician consultations
- • Study medication or treatment provided
IRB-approved study. Free to apply. Your information is kept confidential.
Ready to Find a Paid Study?
Join over 100,000 people who have been matched with clinical studies. It's free, fast, and could change your life.